Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial

BACKGROUND: Neoadjuvant chemotherapy before surgery improves survival compared with surgery alone for patients with oesophageal cancer. The OE05 trial assessed whether increasing the duration and intensity of neoadjuvant chemotherapy further improved survival compared with the current standard regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Alderson, Derek, Cunningham, David, Nankivell, Matthew, Blazeby, Jane M, Griffin, S Michael, Crellin, Adrian, Grabsch, Heike I, Langer, Rupert, Pritchard, Susan, Okines, Alicia, Krysztopik, Richard, Coxon, Fareeda, Thompson, Joyce, Falk, Stephen, Robb, Clare, Stenning, Sally, Langley, Ruth E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585417/
https://www.ncbi.nlm.nih.gov/pubmed/28784312
http://dx.doi.org/10.1016/S1470-2045(17)30447-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585417/
https://www.ncbi.nlm.nih.gov/pubmed/28784312
http://dx.doi.org/10.1016/S1470-2045(17)30447-3

Ejemplares similares